Detalhe da pesquisa
1.
Breakthrough COVID-19 cases despite prophylaxis with 150 mg of tixagevimab and 150 mg of cilgavimab in kidney transplant recipients.
Am J Transplant
; 22(11): 2675-2681, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35713984
2.
A rapid decline in the anti-receptor-binding domain of the SARS-CoV-2 spike protein IgG titer in kidney transplant recipients after tixagevimab-cilgavimab administration.
Kidney Int
; 102(5): 1188-1190, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35973595
3.
Intrinsic capacity and frailty in older adults with end-stage kidney disease undergoing pre-kidney transplant comprehensive geriatric assessment.
J Nutr Health Aging
; 28(6): 100236, 2024 Apr 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38643611
4.
Primary hyperoxaluria in adults and children: a nationwide cohort highlights a persistent diagnostic delay.
Clin Kidney J
; 17(5): sfae099, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38737343
5.
Prediction of Vaccine Response and Development of a Personalized Anti-SARS-CoV-2 Vaccination Strategy in Kidney Transplant Recipients: Results from a Large Single-Center Study.
J Pers Med
; 12(7)2022 Jul 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35887604
6.
Prediction Tool to Estimate Potassium Diet in Chronic Kidney Disease Patients Developed Using a Machine Learning Tool: The UniverSel Study.
Nutrients
; 14(12)2022 Jun 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35745151
7.
Tixagevimab-cilgavimab as an Early Treatment for COVID-19 in Kidney Transplant Recipients.
Transplantation
; 107(8): e215-e218, 2023 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37340538
8.
Superparamagnetic nanoparticles as vectors for inner ear treatments: driving and toxicity evaluation.
Acta Otolaryngol
; 136(4): 402-8, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-26982172